Par Pharmaceuticals is a pharmaceutical company that develops, manufactures, and distributes generic drugs. The company was founded in 1978 and is headquartered in Chestnut Ridge, New York. Par Pharmaceuticals' products are used to treat a wide range of medical conditions, including cardiovascular disease, cancer, and infectious diseases. The company has a strong commitment to quality and safety, and works to ensure that its products meet the highest standards of efficacy and purity. Par Pharmaceuticals is a subsidiary of Endo International plc, a global specialty pharmaceutical company.